Global and United States In Vitro Colorectal Cancer Testing Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 In Vitro Colorectal Cancer Testing Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global In Vitro Colorectal Cancer Testing Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global In Vitro Colorectal Cancer Testing Market Size for the Year 2017-2028
  • 1.2.2 Global In Vitro Colorectal Cancer Testing Market Size for the Year 2017-2028
• 1.3 In Vitro Colorectal Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States In Vitro Colorectal Cancer Testing in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of In Vitro Colorectal Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 In Vitro Colorectal Cancer Testing Market Dynamics
  • 1.4.1 In Vitro Colorectal Cancer Testing Industry Trends
  • 1.4.2 In Vitro Colorectal Cancer Testing Market Drivers
  • 1.4.3 In Vitro Colorectal Cancer Testing Market Challenges
  • 1.4.4 In Vitro Colorectal Cancer Testing Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 In Vitro Colorectal Cancer Testing by Type

• 2.1 In Vitro Colorectal Cancer Testing Market Segment by Type
  • 2.1.1 Fecal Occult Blood Tests
  • 2.1.2 Stool Biomarkers Tests
  • 2.1.3 Blood Biomarker Tests
• 2.2 Global In Vitro Colorectal Cancer Testing Market Size by Type (2017, 2022 & 2028)
• 2.3 Global In Vitro Colorectal Cancer Testing Market Size by Type (2017-2028)
• 2.4 United States In Vitro Colorectal Cancer Testing Market Size by Type (2017, 2022 & 2028)
• 2.5 United States In Vitro Colorectal Cancer Testing Market Size by Type (2017-2028)

3 In Vitro Colorectal Cancer Testing by Application

• 3.1 In Vitro Colorectal Cancer Testing Market Segment by Application
  • 3.1.1 Ambulatory Surgical Centers
  • 3.1.2 Hospitals
  • 3.1.3 Physical Examination Center
• 3.2 Global In Vitro Colorectal Cancer Testing Market Size by Application (2017, 2022 & 2028)
• 3.3 Global In Vitro Colorectal Cancer Testing Market Size by Application (2017-2028)
• 3.4 United States In Vitro Colorectal Cancer Testing Market Size by Application (2017, 2022 & 2028)
• 3.5 United States In Vitro Colorectal Cancer Testing Market Size by Application (2017-2028)

4 Global In Vitro Colorectal Cancer Testing Competitor Landscape by Company

• 4.1 Global In Vitro Colorectal Cancer Testing Market Size by Company
  • 4.1.1 Top Global In Vitro Colorectal Cancer Testing Companies Ranked by Revenue (2021)
  • 4.1.2 Global In Vitro Colorectal Cancer Testing Revenue by Player (2017-2022)
• 4.2 Global In Vitro Colorectal Cancer Testing Concentration Ratio (CR)
  • 4.2.1 In Vitro Colorectal Cancer Testing Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of In Vitro Colorectal Cancer Testing in 2021
  • 4.2.3 Global In Vitro Colorectal Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global In Vitro Colorectal Cancer Testing Headquarters, Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global In Vitro Colorectal Cancer Testing Headquarters and Area Served
  • 4.3.2 Global In Vitro Colorectal Cancer Testing Companies Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into In Vitro Colorectal Cancer Testing Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States In Vitro Colorectal Cancer Testing Market Size by Company
  • 4.5.1 Top In Vitro Colorectal Cancer Testing Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States In Vitro Colorectal Cancer Testing Revenue by Players (2020, 2021 & 2022)

5 Global In Vitro Colorectal Cancer Testing Market Size by Region

• 5.1 Global In Vitro Colorectal Cancer Testing Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global In Vitro Colorectal Cancer Testing Market Size by Region (2017-2028)
  • 5.2.1 Global In Vitro Colorectal Cancer Testing Market Size by Region: 2017-2022
  • 5.2.2 Global In Vitro Colorectal Cancer Testing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America In Vitro Colorectal Cancer Testing Market Size YoY Growth 2017-2028
  • 6.1.2 North America In Vitro Colorectal Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific In Vitro Colorectal Cancer Testing Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific In Vitro Colorectal Cancer Testing Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe In Vitro Colorectal Cancer Testing Market Size YoY Growth 2017-2028
  • 6.3.2 Europe In Vitro Colorectal Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America In Vitro Colorectal Cancer Testing Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America In Vitro Colorectal Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa In Vitro Colorectal Cancer Testing Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa In Vitro Colorectal Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Abbott Laboratories
  • 7.1.1 Abbott Laboratories Company Details
  • 7.1.2 Abbott Laboratories Business Overview
  • 7.1.3 Abbott Laboratories In Vitro Colorectal Cancer Testing Introduction
  • 7.1.4 Abbott Laboratories Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.1.5 Abbott Laboratories Recent Development
• 7.2 BioTime
  • 7.2.1 BioTime Company Details
  • 7.2.2 BioTime Business Overview
  • 7.2.3 BioTime In Vitro Colorectal Cancer Testing Introduction
  • 7.2.4 BioTime Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.2.5 BioTime Recent Development
• 7.3 Danaher Corporation
  • 7.3.1 Danaher Corporation Company Details
  • 7.3.2 Danaher Corporation Business Overview
  • 7.3.3 Danaher Corporation In Vitro Colorectal Cancer Testing Introduction
  • 7.3.4 Danaher Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.3.5 Danaher Corporation Recent Development
• 7.4 Epigenomics AG
  • 7.4.1 Epigenomics AG Company Details
  • 7.4.2 Epigenomics AG Business Overview
  • 7.4.3 Epigenomics AG In Vitro Colorectal Cancer Testing Introduction
  • 7.4.4 Epigenomics AG Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.4.5 Epigenomics AG Recent Development
• 7.5 Exact Sciences Corporation
  • 7.5.1 Exact Sciences Corporation Company Details
  • 7.5.2 Exact Sciences Corporation Business Overview
  • 7.5.3 Exact Sciences Corporation In Vitro Colorectal Cancer Testing Introduction
  • 7.5.4 Exact Sciences Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.5.5 Exact Sciences Corporation Recent Development
• 7.6 LifeLabs Medical Laboratory Services
  • 7.6.1 LifeLabs Medical Laboratory Services Company Details
  • 7.6.2 LifeLabs Medical Laboratory Services Business Overview
  • 7.6.3 LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Introduction
  • 7.6.4 LifeLabs Medical Laboratory Services Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.6.5 LifeLabs Medical Laboratory Services Recent Development
• 7.7 Novigenix SA
  • 7.7.1 Novigenix SA Company Details
  • 7.7.2 Novigenix SA Business Overview
  • 7.7.3 Novigenix SA In Vitro Colorectal Cancer Testing Introduction
  • 7.7.4 Novigenix SA Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.7.5 Novigenix SA Recent Development
• 7.8 Quest Diagnostics
  • 7.8.1 Quest Diagnostics Company Details
  • 7.8.2 Quest Diagnostics Business Overview
  • 7.8.3 Quest Diagnostics In Vitro Colorectal Cancer Testing Introduction
  • 7.8.4 Quest Diagnostics Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.8.5 Quest Diagnostics Recent Development
• 7.9 Sysmex Corporation
  • 7.9.1 Sysmex Corporation Company Details
  • 7.9.2 Sysmex Corporation Business Overview
  • 7.9.3 Sysmex Corporation In Vitro Colorectal Cancer Testing Introduction
  • 7.9.4 Sysmex Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2017-2022)
  • 7.9.5 Sysmex Corporation Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details